<img data-src="https://erdservices.org/wp-content/uploads/2019/12/Charles_River-MA.png" class="img-responsive lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 384px; --smush-placeholder-aspect-ratio: 384/192;"><noscript><img src="https://erdservices.org/wp-content/uploads/2019/12/Charles_River-MA.png" class="img-responsive">

Charles River Gains Large Molecules Expertise, Targeting Biotechs

/ January 13, 2021

Charles River Labs (CRL) will gain further expertise for biotechs. The company is to acquire San Francisco-based Distributed Bio, a large molecules specialist firm focusing on antibody discovery. Distributed Bio will become part of CRL’s core R&D business, Discovery & Safety Assessment.

<img data-src="https://erdservices.org/wp-content/uploads/2019/12/Charles_River-MA.png" class="img-responsive lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 384px; --smush-placeholder-aspect-ratio: 384/192;"><noscript><img src="https://erdservices.org/wp-content/uploads/2019/12/Charles_River-MA.png" class="img-responsive">

Charles River Acquires Cellero for its HemaCare Business

/ September 6, 2020

In August, CRL acquired a small firm, Cellero, headquartered close to Boston for USD 38m. Cellero brought a geography presence to HEMA (which is based in California).

<img data-src="https://erdservices.org/wp-content/uploads/2019/12/Charles_River-MA.png" class="img-responsive lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" style="--smush-placeholder-width: 384px; --smush-placeholder-aspect-ratio: 384/192;"><noscript><img src="https://erdservices.org/wp-content/uploads/2019/12/Charles_River-MA.png" class="img-responsive">

Charles River Labs Acquires Hemacare for USD 380m

/ December 19, 2019

Become a ERD Services premium reader to access all of your content, by contacting us at dominique@ERDservices.org.